Position in TMO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$211,573
-$31,242 QoQ
Shares Held
422
-14.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#2,258
of 2,606 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Auxano Advisors, LLC holds $211,573 across 1 Diagnostics & Research name. TMO ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
422 | $211,573 |
All Filings in TMO
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $211,573 | 422 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $242,815 | 494 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $298,416 | 515 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $209,528 | 432 | Shares | Sole | 2025-11-05 | |
| 2025-03-31 | $267,708 | 538 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $255,432 | 491 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $322,274 | 521 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $288,113 | 521 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $290,605 | 500 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $202,230 | 381 | Shares | Sole | 2024-02-05 | |
| 2023-06-30 | $198,265 | 380 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $219,020 | 380 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $209,262 | 380 | Shares | Sole | 2023-02-06 | |
| No filing history on record for this holder in this stock. | ||||||